EcoDrugPlus

Ensembl ID : ENSHCOG00000009117
Gene Symbol: -
Cross references: -
15 Possible Orthologues:

Ensembl ID : ENSHCOG00000003696
Gene Symbol: -
Cross references: -
75 Possible Orthologues:

Ensembl ID : ENSHCOG00000002069
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSHCOG00000010635
Gene Symbol: -
Cross references: -
202 Possible Orthologues:

Ensembl ID : ENSHCOG00000009929
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSHCOG00000006964
Gene Symbol: -
Cross references: -
211 Possible Orthologues:

Ensembl ID : ENSHCOG00000009616
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSHCOG00000009450
Gene Symbol: -
Cross references: -
170 Possible Orthologues:

Ensembl ID : ENSHCOG00000009391
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSHCOG00000009374
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSHCOG00000009268
Gene Symbol: -
Cross references: -
201 Possible Orthologues:

Ensembl ID : ENSHCOG00000019229
Gene Symbol: -
Cross references: -
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).